Orpha Biotech develops small molecules for the treatment of systemic sclerosis and juvenile rheumatoid arthritis.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Maglie
State: Puglia
Zip:
Country: Italy
Orpha Biotech is a developer of pharmaceutical drugs using molecular technology designed to treat orphan diseases. They create small-molecule medications to treat juvenile rheumatoid arthritis and cutaneous systemic sclerosis. They use structure-based computational virtual screening and allied docking simulations to discover potential agonists or antagonists.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Pre Seed Round | 1 | $282.6k |
CDP Equity CDP Equity |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|